Estrogenic hormone action in the heart: Regulatory network and function

Cardiovascular Research

Volumn 53, Issue 3, 2002, Pages 709-719

  Babiker, Fawzi A ^a   De Windt, Leon J ^a   Van Eickels, Martin ^b   Grohe, Christian ^c   Meyer, Rainer ^c   Doevendans, Pieter A ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Atherosclerosis; Coronary disease; Gender; Hormones

Indexed keywords

4 (1,2 DIPHENYL 1 BUTENYL)CINNAMIC ACID; ARZOXIFENE; DROLOXIFENE; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; HORMONE DERIVATIVE; IDOXIFENE; MIPROXIFENE PHOSPHATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

BLOOD VESSEL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ESTROGEN THERAPY; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; INDUSTRIALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

CARDIOMEGALY; CARDIOMYOPATHIES; CORONARY DISEASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MYOCARDIUM; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 0037084312     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00526-0     Document Type: Review

References (119)

1. Hormone therapy to prevent disease and prolong life in postmenopausal women
2. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women
3. Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults
4. Estrogen and the blood vessel wall
5. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study
6. Cardiac myocytes and fibroblasts contain functional estrogen receptors
7. Hormone replacement therapy and cardioprotection: Basic concepts and clinical considerations
8. Estrogen, natriuretic peptides and the renin-angiotensin system
9. Expression of oestrogen receptor alpha and beta in rat heart: Role of local oestrogen synthesis
10. The protective effects of estrogen on the cardiovascular system
11. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1
12. 17β-Estradiol attenuates the development of pressure-overload hypertrophy
13. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
14. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
15. Cloning of a novel receptor expressed in rat prostate and ovary
16. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus
17. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro
18. Structure and function of nuclear hormone receptors
19. Estrogen receptor beta - A new dimension in estrogen mechanism of action
20. ER beta: Identification and characterization of a novel human estrogen receptor
21. The carboxy-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
22. B region variant of the estrogen receptor gene
23. Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population
24. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels
25. Estrogen receptors alpha and beta form heterodimers on DNA
26. The steroid and thyroid hormone receptor superfamily
27. Transcription factors and the cardiac gene programme
28. Estrogen receptor accessory proteins augment receptor-DNA interaction and DNA bending
29. Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: Correlation with sex steroid receptors and Ki-67 antigen expression
30. Proteins in the heat shock-70 family specifically bind 25-hydroxyvitamin D3 and 17beta-estradiol
31. Evidence for oestrogenic regulation of heat shock protein expression in human endometrium and steroid-responsive cell lines
32. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts
33. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3
34. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone
35. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter
36. The role of ligand in estrogen receptor regulation of gene expression
37. 17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo
38. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium
39. Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice
40. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes
41. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys
42. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats
43. Regulation of angiotensinogen gene expression by estrogen
44. Age-dependent changes in particulate and soluble guanylyl cyclase activities in urinary tract smooth muscle
45. Molecular biology of the renin-angiotensin system
46. Proximal regulatory domains of rat atrial natriuretic factor gene
47. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats
48. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor
49. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells
50. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
51. Plasma membrane estrogen receptors are coupled to eNOS through G{alpha}i
52. Non-genomic effects of estrogen and the vessel wall
53. 2+ release induced by thromboxane A2 in porcine coronary artery
54. Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle
55. 2+ uptake
56. 2+ currents in A7r5 vascular smooth muscle cell line
57. 2+ channels in smooth muscle cells
58. Investigation of the negative inotropic effects of 17 beta-oestradiol in human isolated myocardial tissues
59. 2+ in guinea-pig isolated cardiac myocytes
60. Modulation of hypertensive heart disease by estrogen
61. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat
62. Acute effects of 17 beta-estradiol on the rat heart
63. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase
64. 2+ mobilization
65. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
66. Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels
67. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism
68. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP
69. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
70. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
71. Dopaminergic and ligand-independent activation of steroid hormone receptors
72. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway
73. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element
74. The roles of gender, the menopause and hormone replacement on cardiovascular function
75. Left ventricular function in men and women. Another difference between sexes
76. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults
77. Sex differences in myocardial contractility in the rat
78. Menopause-related changes in left ventricular function in healthy women
79. The effect of the hypoestrogenic state, induced by gonadotropin-releasing hormone agonist, on Doppler-derived parameters of aortic flow
80. Comparison of heart function in male and female rats
81. In vivo arterial compliance in man
82. Long-term cardiovascular effects of high 'osteoprotective' dose levels of 17 beta-estradiol in spontaneously hypertensive rats
83. Impairment of endothelium-dependent vasorelaxation in experimental atherosclerosis is dependent on gender
84. 17β-Estradiol modulates baroreflex sensitivity and autonomic tone of female rats
85. Early changes induced in the left ventricle by pressure overload. An experimental study on swine heart
86. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: A review
87. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease
88. Successes and failures of current treatment of heart failure
89. Effects of gonadectomy and hormonal replacement on rat hearts
90. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats
91. Hypertrophic remodeling: Gender differences in the early response to left ventricular pressure overload
92. Gene expression profile in mouse myocardium after ischemia
93. Advances in the molecular mechanisms of heart failure
94. Role of growth hormone in chronic heart failure: Therapeutic implications
95. Hypertension: An important precursor of heart failure
96. 2+ exchanger in end-stage human heart failure
97. Molecular cardiology, part 2: Molecular aspects of cardiac hypertrophy and heart failure
98. Cardiac failure in ischemic cardiopathy
99. Estrogen restores role of basal nitric oxide in control of vascular tone in rats with chronic heart failure
100. Myocardial Akt activation and gender: Increased nuclear activity in females versus males
101. The stunned myocardium: Prolonged, postischemic ventricular dysfunction
102. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture
103. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women
104. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
105. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women
106. Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: Effects of estrogen
107. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: Role of nitric oxide and calcium-activated potassium channels
108. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
109. 17β-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion
110. Hormone replacement therapy, heart disease, and other considerations
111. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study
112. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
113. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up
114. Selective estrogen receptor modulators and phytoestrogens: New therapies for the postmenopausal women
115. Selective oestrogen receptor modulators
116. The potential of SERMs for reducing the risk of coronary heart disease
117. Selective estrogen receptor modulators: Structure, function, and clinical use
118. Phytoestrogens - A short review
119. Phytoestrogens and coronary heart disease